Here’s a scenario that plays out more often than you’d expect in Australian manufacturing: a business owner commissions a valuation and discovers that their CNC machines, injection moulding equipment, and factory fit-out are worth more on a liquidation basis than the business as a going concern.
It’s a brutal realisation. You’ve spent twenty years building something — customers, staff, capability — and the numbers say the hardware underneath it all is the most valuable part.
This is the fundamental tension in manufacturing valuations, and understanding it is the starting point for getting the outcome right.
The Asset-vs-Earnings Question
Most businesses are valued on earnings — a multiple of EBITDA or SDE. Manufacturing businesses are too, but with a critical floor: net tangible asset value.
If a manufacturer generates $400K in EBITDA and comparable businesses sell for 4x earnings ($1.6M), but the plant, equipment, and inventory are independently worth $2.1M, the asset value sets the price floor. The buyer is effectively getting the business — customers, staff, systems — for free on top of the asset base.
| Manufacturing Type | Typical EBITDA Multiple | Key Consideration |
|---|---|---|
| Proprietary product manufacturer | 4x – 7x | Brand/IP premium |
| Specialty/custom manufacturer | 4x – 6x | Capability and customer lock-in |
| Food and beverage | 4x – 7x | HACCP, brand value, consumer demand |
| General contract manufacturer | 3x – 5x | Easily substitutable |
| Heavy/capital-intensive | 4x – 6x | Asset base provides floor |
The margin reality in Australian manufacturing: typical net margins sit between 5% and 12%. If you’re consistently above 12%, you either have proprietary products, a niche with limited competition, or exceptional operational efficiency — and buyers will pay accordingly. Below 5%, and you’re likely trapped in commodity contract manufacturing where the buyer is really buying your equipment and customer list.
Proprietary Products vs Contract Manufacturing: A Valuation Chasm
Nothing shifts a manufacturing valuation more than the answer to one question: do you own what you make?
Proprietary product manufacturers — those with their own brands, patented designs, or proprietary formulations — command multiples at the top of the range. The IP creates a moat. A competitor can buy the same equipment, but they can’t replicate your product without your designs, tooling, or recipes.
Contract manufacturers — those making products to someone else’s specifications — are far more substitutable. Your customer’s engineering team designed the part; you just make it. If you lose the contract, the customer takes their drawings to the next shop. Multiples reflect this risk.
The middle ground is capability-based manufacturing — where you’ve developed specialised processes, tooling, or expertise that make you difficult to replace even though you don’t own the end product IP. Aerospace-certified welding, pharmaceutical-grade cleanroom manufacturing, or food-grade processing with established HACCP plans all create switching costs that lift valuations above pure contract manufacturing.
The Capex Cycle Trap
Manufacturing is capital-intensive, and the timing of equipment investment creates a genuine valuation trap.
If your key equipment is nearing end-of-life, a buyer will discount the purchase price by the expected replacement cost. A five-axis CNC that needs replacing in two years represents a $300,000–$800,000 future liability. But if you invest in new equipment before selling, you’ve spent the capital without necessarily recouping it in a higher sale price — because the valuation uplift from new equipment rarely matches what you paid for it.
The pragmatic approach:
- Maintain impeccably. Equipment that’s old but well-maintained with full service records is far more valuable than equipment of the same age that’s been run hard.
- Invest selectively. Replace equipment that’s genuinely failing or limiting capacity. Don’t undertake a wholesale fleet upgrade just to impress buyers.
- Document everything. Service logs, condition assessments, and remaining useful life estimates for every significant asset. Buyers’ due diligence teams will request this.
Inventory and Work-in-Progress: Where Deals Get Complicated
Inventory is typically added at cost on top of the business valuation, but “at cost” is where arguments start.
Raw materials are straightforward if they’re current and usable. Obsolete stock — that pallet of aluminium extrusion you bought for a job that got cancelled in 2022 — gets written down or excluded entirely.
Work-in-progress is harder. Partially completed jobs have cost embedded in them (materials, labour, machine time) but no realisable value until they’re finished and delivered. Buyers will want to understand the WIP schedule in detail: what stage is each job at, what’s the margin on completion, and what’s the delivery timeline?
Finished goods held in stock carry their own risk. How long have they been there? Is the customer committed to taking them? Slow-moving finished goods inventory signals demand problems.
Practical advice: conduct a full inventory count and write-down 3–6 months before going to market. This is painful — writing off $200K of obsolete stock hits your P&L — but presenting a clean, current inventory at realistic values is far better than having a buyer’s accountant shred your inventory figure during due diligence.
Supply Chain and Customer Relationships as Value
In contract and specialty manufacturing, your relationships are structural assets:
Customer concentration is the biggest red flag. If one customer represents 40% of revenue, the entire business valuation is contingent on that relationship continuing. Buyers either discount heavily for concentration risk or structure earn-outs around key customer retention.
Long-term supply agreements — formal contracts with 2–5 year terms and minimum volumes — are genuinely valuable. They provide the revenue visibility that justifies an earnings multiple.
Approved supplier status with major OEMs, government bodies, or regulated industries takes years to earn and creates real switching costs. Being on the approved supplier list for a defence contractor or automotive OEM is worth more than most owners realise.
ISO and Quality Certifications
ISO 9001 is effectively table stakes for any manufacturing business targeting trade buyers or PE. Not having it limits your buyer pool significantly. ISO 14001 (environmental) and ISO 45001 (safety) add incremental value but aren’t deal-breakers.
Industry-specific certifications matter more: HACCP for food manufacturing, AS/NZS 1554 for structural welding, TGA licensing for therapeutic goods. These represent genuine barriers to entry and are often the reason a buyer chooses acquisition over organic build.
What Moves the Needle
If you’re 12–24 months from a potential sale:
- Get clear on your asset register. Independent valuations of plant and equipment establish the floor.
- Diversify your customer base. If one customer is over 25% of revenue, actively pursue new business to dilute concentration.
- Secure or extend key supply agreements. Written contracts beat handshake relationships every time.
- Address environmental compliance. Contamination issues, waste handling non-compliance, or EPA notices can kill a deal entirely. Resolve them before going to market.
- Invest in quality systems. If you don’t have ISO 9001, get it. The process takes 6–12 months and opens your buyer pool significantly.
Get an indicative valuation for your manufacturing business or contact us to discuss your situation confidentially.